Literature DB >> 12402575

Factor structure of the Young Mania Rating Scale for use with youths ages 5 to 17 years.

Eric A Youngstrom1, Carla Kmett Danielson, Robert L Findling, Barbara L Gracious, Joseph R Calabrese.   

Abstract

Assessed the factor structure of the Young Mania Rating Scale (YMRS). Youths presenting to a research program specializing in the pharmacological treatment of mood and disruptive behavioral disorders (N = 612) were administered a semistructured diagnostic interview. Based on the interview, youths were placed into diagnostic groups. Highly trained raters completed the YMRS for each youth. YMRS ratings were internally consistent (alpha = .91), and exploratory and confirmatory factor analyses yielded a 1-factor solution for boys and girls in both young (5 to 11 years) and older (12 to 17 years) subsamples. However, the young male group showed higher scores on several items as well as the total YMRS score. Results suggest that the YMRS total score can be meaningfully interpreted in child and adolescent samples.

Entities:  

Mesh:

Year:  2002        PMID: 12402575     DOI: 10.1207/S15374424JCCP3104_15

Source DB:  PubMed          Journal:  J Clin Child Adolesc Psychol        ISSN: 1537-4416


  37 in total

1.  Validity of the Expressed Emotion Adjective Checklist (EEAC) in Caregivers of Children with Mood Disorders.

Authors:  Nicole M Klaus; Guillermo Perez Algorta; Andrea S Young; Mary A Fristad
Journal:  Couple Family Psychol       Date:  2015-03

2.  Characteristics of children with elevated symptoms of mania: the Longitudinal Assessment of Manic Symptoms (LAMS) study.

Authors:  Robert L Findling; Eric A Youngstrom; Mary A Fristad; Boris Birmaher; Robert A Kowatch; L Eugene Arnold; Thomas W Frazier; David Axelson; Neal Ryan; Christine A Demeter; Mary Kay Gill; Benjamin Fields; Judith Depew; Shawn M Kennedy; Linda Marsh; Brieana M Rowles; Sarah McCue Horwitz
Journal:  J Clin Psychiatry       Date:  2010-10-05       Impact factor: 4.384

3.  Three-year latent class trajectories of attention-deficit/hyperactivity disorder (ADHD) symptoms in a clinical sample not selected for ADHD.

Authors:  L Eugene Arnold; Stephen J Ganocy; Katherine Mount; Eric A Youngstrom; Thomas Frazier; Mary Fristad; Sarah M Horwitz; Boris Birmaher; Robert Findling; Robert A Kowatch; Christine Demeter; David Axelson; Mary Kay Gill; Linda Marsh
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-04-30       Impact factor: 8.829

4.  Sleep-Wake Patterns of Adolescents with Borderline Personality Disorder and Bipolar Disorder.

Authors:  Christophe Huỳnh; Jean-Marc Guilé; Jean-Jacques Breton; Roger Godbout
Journal:  Child Psychiatry Hum Dev       Date:  2016-04

5.  Anxiety in children with mood disorders: a treatment help or hindrance?

Authors:  Colleen M Cummings; Mary A Fristad
Journal:  J Abnorm Child Psychol       Date:  2012-04

6.  Psychometric properties of the Treatment-Emergent Activation and Suicidality Assessment Profile (TEASAP) in youth with OCD.

Authors:  Regina Bussing; Tanya K Murphy; Eric A Storch; Joseph P H McNamara; Adam M Reid; Cynthia W Garvan; Wayne K Goodman
Journal:  Psychiatry Res       Date:  2012-09-29       Impact factor: 3.222

7.  Examination of disruptive behavior outcomes and moderation in a randomized psychotherapy trial for mood disorders.

Authors:  Khrista Boylan; Heather A Macpherson; Mary A Fristad
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-07       Impact factor: 8.829

8.  Portability of a screener for pediatric bipolar disorder to a diverse setting.

Authors:  Andrew J Freeman; Eric A Youngstrom; Thomas W Frazier; Jennifer Kogos Youngstrom; Christine Demeter; Robert L Findling
Journal:  Psychol Assess       Date:  2011-09-26

9.  Efficacy, long-term safety, and tolerability of ziprasidone in children and adolescents with bipolar disorder.

Authors:  Robert L Findling; Idil Cavuş; Elizabeth Pappadopulos; Douglas G Vanderburg; Jeffrey H Schwartz; Balarama K Gundapaneni; Melissa P DelBello
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-10-10       Impact factor: 2.576

10.  Clinical significance of treatment effects with aripiprazole versus placebo in a study of manic or mixed episodes associated with pediatric bipolar I disorder.

Authors:  Eric Youngstrom; Joan Zhao; Raymond Mankoski; Robert A Forbes; Ronald M Marcus; William Carson; Robert McQuade; Robert L Findling
Journal:  J Child Adolesc Psychopharmacol       Date:  2013-03-12       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.